FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W768856779> ?p ?o ?g. }

• W768856779 abstract "Microglia are specialized macrophages of the central nervous system involved in immune regulation, tissue development, homeostasis and wound repair. In healthy tissue, microglia are found in a ramified state which is tightly controlled by neurons. Upon insult, microglia undergo morphological changes, resembling active phagocytic macrophages and are highly motile. In neurodegenerative diseases, such are Alzheimer's or multiple sclerosis and in most inherited retinal dystrophies, microglia cells are found in a permanent pro-inflammatory active state which exacerbates cell death and disease progression. Similarly, astrocytes in the brain or Muller cells in the retina, also become reactive in diseased tissue and may contribute to disease progression through overshoot release of protective factors such as VEGF (vascular endothelial growth factor), massive proliferation and release of inflammatory intermediates which recruit microglia to site of injury. Along with active microglia, reactive astrocytes/Muller cells are also found in virtually all neurodegenerative and retinal dystrophies. Microglia and Muller cell status has not been well defined in retinal degeneration of neurodegenerative disease neuronal ceroid lipofuscinosis (NCL). The NCLs are early onset lysosomal storage disorders characterized by vision loss, mental and motor deficits, and spontaneous seizures. Massive accumulation of auto-fluorescent material in neurons lead to progressive neuronal degeneration and cell death Furthermore, neuropathological analyses of autopsy material from NCL patients and animal models revealed brain atrophy closely associated with microglial and astrocyte activity. However, it is unclear whether this phenomenon is mainly confined to the brain or also occurs in the retina Two mouse models of NCL, Cln3Δex7-8 and Cln6nclf, were selected for detailed characterization of retinal degeneration with focus on microglia and Muller cell activity. Studies showed that Cln3Δex7-8 mice had a late onset of retinal degeneration which started at 9 months and progressed until severe retinal impairment at 18 months. Reactive Muller cells were present starting at six months with no significant microglial activation until late disease stage. Furthermore, degeneration originated from inner retinal cells as seen through electroretinograms with little photoreceptor death. In contrast, temporal studies on Cln6nclf mice showed an early progressive retinal degenerative phenotype which started before one month of age resulting in loss of vision and retinal function by eight months. Full retinal degeneration was accompanied by reactive Muller cells already present at one month of age and fully active microglia at four months. Mixed population of ramified and active microglia were seen at one month. Transcript profiling of the Cln6ncl mouse retina also showed up-regulated expression of apoptotic, inflammatory and active microglia markers. Based on the strong reactivity of microglia, Cln6nclf mice were supplemented with immuno-modulatory compounds curcumin, luteolin or DHA in order to ameliorate microgliosis and reduce retinal degeneration. Studies showed Cln6nclf mice supplemented with 0.6% curcumin, 0.6% luteolin or 5% DHA had improved retinal function, better visual acuity and DHA-supplementation had the greatest preservation of photoreceptors. All supplements were able to attenuate microglia activation as seen by the presence of microglial ramification and intact network. However, curcumin and luteolin supplementation did not have any effect on retinal transcriptom whilst DHA-supplementation reduced expression of inflammatory and apoptotic markers.Taken together, microglial reactivity accompanies disease progression in the Cln6nclf retina but not Cln3Δex7-8. Immuno-modulating compounds were able to attenuate disease progression and reactive microglia to a certain extent in Cln6nclf mice, indicating modulation of microglial activity could be helpful in preserving vision and may ameliorate neuronal degeneration in NCL. Finally, inspection of the retinal function may also allow to monitor general disease progression and could be used to assess the efficacy of therapeutic interventions for NCL patients." @default.
• W768856779 created "2016-06-24" @default.
• W768856779 creator A5060511760 @default.
• W768856779 date "2013-10-16" @default.
• W768856779 modified "2023-09-27" @default.
• W768856779 title "Characterization of the retinal degeneration and glial activation of neuronal ceroid lipofuscinosis mouse models Cln3Δex7-8 and Cln6nclf and the beneficial effects of dietary supplementation" @default.
• W768856779 hasPublicationYear "2013" @default.
• W768856779 type Work @default.
• W768856779 sameAs 768856779 @default.
• W768856779 citedByCount "0" @default.
• W768856779 crossrefType "dissertation" @default.
• W768856779 hasAuthorship W768856779A5060511760 @default.
• W768856779 hasConcept C142724271 @default.
• W768856779 hasConcept C169760540 @default.
• W768856779 hasConcept C203014093 @default.
• W768856779 hasConcept C2776914184 @default.
• W768856779 hasConcept C2777093970 @default.
• W768856779 hasConcept C2778230176 @default.
• W768856779 hasConcept C2778650512 @default.
• W768856779 hasConcept C2779134260 @default.
• W768856779 hasConcept C2779830541 @default.
• W768856779 hasConcept C2780827179 @default.
• W768856779 hasConcept C2781040256 @default.
• W768856779 hasConcept C55493867 @default.
• W768856779 hasConcept C71924100 @default.
• W768856779 hasConcept C86803240 @default.
• W768856779 hasConceptScore W768856779C142724271 @default.
• W768856779 hasConceptScore W768856779C169760540 @default.
• W768856779 hasConceptScore W768856779C203014093 @default.
• W768856779 hasConceptScore W768856779C2776914184 @default.
• W768856779 hasConceptScore W768856779C2777093970 @default.
• W768856779 hasConceptScore W768856779C2778230176 @default.
• W768856779 hasConceptScore W768856779C2778650512 @default.
• W768856779 hasConceptScore W768856779C2779134260 @default.
• W768856779 hasConceptScore W768856779C2779830541 @default.
• W768856779 hasConceptScore W768856779C2780827179 @default.
• W768856779 hasConceptScore W768856779C2781040256 @default.
• W768856779 hasConceptScore W768856779C55493867 @default.
• W768856779 hasConceptScore W768856779C71924100 @default.
• W768856779 hasConceptScore W768856779C86803240 @default.
• W768856779 hasLocation W7688567791 @default.
• W768856779 hasOpenAccess W768856779 @default.
• W768856779 hasPrimaryLocation W7688567791 @default.
• W768856779 hasRelatedWork W1613918123 @default.
• W768856779 hasRelatedWork W188801899 @default.
• W768856779 hasRelatedWork W1968909886 @default.
• W768856779 hasRelatedWork W1973659906 @default.
• W768856779 hasRelatedWork W2023038089 @default.
• W768856779 hasRelatedWork W2028545133 @default.
• W768856779 hasRelatedWork W2031345309 @default.
• W768856779 hasRelatedWork W2063005088 @default.
• W768856779 hasRelatedWork W2090450669 @default.
• W768856779 hasRelatedWork W2098865320 @default.
• W768856779 hasRelatedWork W2141273703 @default.
• W768856779 hasRelatedWork W2143346315 @default.
• W768856779 hasRelatedWork W2620266814 @default.
• W768856779 hasRelatedWork W2768433279 @default.
• W768856779 hasRelatedWork W2885318766 @default.
• W768856779 hasRelatedWork W2904003882 @default.
• W768856779 hasRelatedWork W2909426653 @default.
• W768856779 hasRelatedWork W2940851310 @default.
• W768856779 hasRelatedWork W3107699784 @default.
• W768856779 hasRelatedWork W3120102977 @default.
• W768856779 isParatext "false" @default.
• W768856779 isRetracted "false" @default.
• W768856779 magId "768856779" @default.
• W768856779 workType "dissertation" @default.